3 Black Friday Bargains: Barclays PLC, GlaxoSmithKline plc And Tesco PLC

Forget Black Friday, Barclays PLC (LON:BARC), GlaxoSmithKline plc (LON:GSK) and Tesco PLC (LON:TSCO) are the real bargains to buy this week

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s one of the biggest shopping weeks of the year, with Black Friday whipping consumers into a pre-Christmas frenzy by offering huge discounts in the shops.

The FTSE 100 is also throwing up some amazing discounts right now, and they will ultimately make you richer, rather than poorer. Here are my three favourite Black Friday bargains: Barclays (LSE: BARC) (NYSE: BCS.US), GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and Tesco (LSE: TSCO).

Barclays

At 237p, big bad bank Barclays is down 20% from its 52-week high of 297p… but it is showing signs of a recovery, following a solid 5% rise in Q3 profits to £4.94bn.

Barclays still faces a string of threats, including market rigging penalites, mis-selling scandals, challenger banks, crashing investment bank profits (down 38% in Q3) and an ongoing investigation into the current account market.

It has also shown signs of capital inadequacy, with a £12.8bn hole in its balance sheet. At Barclays, every day seems like Black Friday.

The outlook should slowly brighten as the billions keep rolling in, the dividend yield (now 2.73%) is repaired, and reputational damage finally patched up.

Barclays’ core businesses are delivering a return on equity of 10.5%, driven by personal and corporate banking, and the strength of its market-leading credit card Barclaycard.

These are solid operations, and you can buy them at a discount today.

GlaxoSmithKline

Trading at 1475p, GlaxoSmithKline is still 14% off its 52-week high, but the gap is starting to narrow. Its share price is up 7% in the last month, but it still offers one of the most enticing yields on the FTSE 100.

Glaxo currently yields 5.3%, more than 10 times base rate. Better still, today’s valuation of 13 times earnings (against 15 or 16 times) makes this a true Black Friday bargain.

Falling pharmaceuticals and vaccine sales in the US, disappointments in its consumer healthcare division, and the threat of further action over the Chinese bribery scandal have painted 2014 black for Glaxo. But unlike the bankers, I reckon it will learn its lessons quickly. And while you wait, keep re-investing those dividends.

Tesco

Britain’s biggest supermarket is so cheap it is almost impossible to resist, and even harder to trust. At 195p, its share price is 44% below its 52-week high. Customers hate it, investors hate it, regulators hate it: what’s to like?

Well, it’s under new management, and new boss Dave Lewis has a free hand to turn things round. Staff may go, stores may close, prices may fall and Tesco Bank may be sold off.

Almost anything could happen at Tesco right now. It is quite a gamble, even at 6.1 times earnings, but that’s how it’s is in the sales. You never really know if you’ve bagged a bargain, until you get it home.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. The Motley Fool UK owns shares of Tesco. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young female business analyst looking at a graph chart while working from home
Investing Articles

Is Avon Protection the best stock to buy in the FTSE All-Share index right now?

Here’s a stock I’m holding for recovery and growth from the FTSE All-Share index. Can it be crowned as the…

Read more »

Investing Articles

Down 8.5% this month, is the Aviva share price too attractive to ignore?

It’s time to look into Aviva and the insurance sector while the share price is pulling back from year-to-date highs.

Read more »

Investing Articles

Here’s where I see Vodafone’s share price ending 2024

Valued at just twice its earnings, is the Vodafone share price a bargain or value trap? Our writer explores where…

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

The Darktrace share price jumped 20% today. Here’s why!

After the Darktrace share price leapt by a fifth in early trading, our writer explains why -- and what it…

Read more »

Dividend Shares

850 shares in this dividend giant could make me £1.1k in passive income

Jon Smith flags up one dividend stock for passive income that has outperformed its sector over the course of the…

Read more »

Investing Articles

Unilever shares are flying! Time to buy at a 21% ‘discount’?

Unilever shares have been racing higher this week after a one-two punch of news from the company. Here’s whether I…

Read more »

artificial intelligence investing algorithms
Market Movers

The Microsoft share price surges after results. Is this the best AI stock to buy?

Jon Smith flags up the jump in the Microsoft share price after the latest results showed strong demand for AI…

Read more »

Google office headquarters
Investing Articles

A dividend announcement sends the Alphabet share price soaring. Here’s what investors need to know

As the Alphabet share price surges on the announcement of a dividend, Stephen Wright outlines what investors should really be…

Read more »